Literature DB >> 16489544

Development of a QSAR model for binding of tripeptides and tripeptidomimetics to the human intestinal di-/tripeptide transporter hPEPT1.

Rikke Andersen1, Flemming Steen Jørgensen, Lars Olsen, Jon Våbenø, Karina Thorn, Carsten Uhd Nielsen, Bente Steffansen.   

Abstract

PURPOSE: The aim of this study was to develop a three-dimensional quantitative structure-activity relationship (QSAR) model for binding of tripeptides and tripeptidomimetics to hPEPT1 based on a series of 25 diverse tripeptides.
METHODS: VolSurf descriptors were generated and correlated with binding affinities by multivariate data analysis. The affinities for hPEPT1 of the tripeptides and tripeptidomimetics were determined experimentally by use of Caco-2 cell monolayers.
RESULTS: The Ki-values of the 25 tripeptides and tripeptidomimetics ranged from 0.15 to 25 mM and the structural diversity of the compounds was described by VolSurf descriptors. A QSAR model that correlated the VolSurf descriptors of the tripeptides with their experimental binding affinity for hPEPT1 was established.
CONCLUSION: Structural information on tripeptide properties influencing the binding to hPEPT1 was extracted from the QSAR model. This information may contribute to the drug design process of tripeptides and tripeptidomimetics where hPEPT1 is targeted as an absorptive transporter for improvement of intestinal absorption. To our knowledge, this is the first time a correlation between VolSurf descriptors and binding affinities for hPEPT1 has been reported.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16489544     DOI: 10.1007/s11095-006-9462-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  How to Make Drugs Orally Active: A Substrate Template for Peptide Transporter PepT1.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  2000-02       Impact factor: 15.336

2.  VolSurf: a new tool for the pharmacokinetic optimization of lead compounds.

Authors:  G Cruciani; M Pastor; W Guba
Journal:  Eur J Pharm Sci       Date:  2000-10       Impact factor: 4.384

Review 3.  Intestinal absorption of peptides.

Authors:  D M Matthews
Journal:  Physiol Rev       Date:  1975-10       Impact factor: 37.312

4.  Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures.

Authors:  C Shu; H Shen; U Hopfer; D E Smith
Journal:  Drug Metab Dispos       Date:  2001-10       Impact factor: 3.922

5.  The role of water in sequence-independent ligand binding by an oligopeptide transporter protein.

Authors:  J R Tame; S H Sleigh; A J Wilkinson; J E Ladbury
Journal:  Nat Struct Biol       Date:  1996-12

6.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

Authors:  E Kaiser; R L Colescott; C D Bossinger; P I Cook
Journal:  Anal Biochem       Date:  1970-04       Impact factor: 3.365

7.  Expression cloning of a mammalian proton-coupled oligopeptide transporter.

Authors:  Y J Fei; Y Kanai; S Nussberger; V Ganapathy; F H Leibach; M F Romero; S K Singh; W F Boron; M A Hediger
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

8.  Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line.

Authors:  C U Nielsen; R Andersen; B Brodin; S Frokjaer; M E Taub; B Steffansen
Journal:  J Control Release       Date:  2001-09-11       Impact factor: 9.776

9.  Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinopril.

Authors:  D I Friedman; G L Amidon
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200

Review 10.  The intestinal H+/peptide symporter PEPT1: structure-affinity relationships.

Authors:  Matthias Brandsch; Ilka Knütter; Frederick H Leibach
Journal:  Eur J Pharm Sci       Date:  2004-01       Impact factor: 4.384

View more
  5 in total

Review 1.  Bioavailability through PepT1: the role of computer modelling in intelligent drug design.

Authors:  David W Foley; Jeyaganesh Rajamanickam; Patrick D Bailey; David Meredith
Journal:  Curr Comput Aided Drug Des       Date:  2010-03       Impact factor: 1.606

Review 2.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

3.  A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1).

Authors:  Diana Højmark Omkvist; Simon Birksø Larsen; Carsten Uhd Nielsen; Bente Steffansen; Lars Olsen; Flemming Steen Jørgensen; Birger Brodin
Journal:  AAPS J       Date:  2010-05-08       Impact factor: 4.009

4.  The tandem chain extension aldol reaction used for synthesis of ketomethylene tripeptidomimetics targeting hPEPT1.

Authors:  Karina Thorn; Carsten Uhd Nielsen; Palle Jakobsen; Bente Steffansen; Charles K Zercher; Mikael Begtrup
Journal:  Bioorg Med Chem Lett       Date:  2011-06-06       Impact factor: 2.823

5.  Artificial neural network models for prediction of intestinal permeability of oligopeptides.

Authors:  Eunkyoung Jung; Junhyoung Kim; Minkyoung Kim; Dong Hyun Jung; Hokyoung Rhee; Jae-Min Shin; Kihang Choi; Sang-Kee Kang; Min-Kook Kim; Cheol-Heui Yun; Yun-Jaie Choi; Seung-Hoon Choi
Journal:  BMC Bioinformatics       Date:  2007-07-11       Impact factor: 3.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.